## Note
nid: 1506458134794
model: AnKingOverhaul
tags: #AK_Original_Decks::Step_1::Lolnotacop::Bugs, #AK_Step1_v11::!FLAG_THESE_CARDS::!DELETE, #AK_Step1_v11::#AMBOSS::Respiratory, #AK_Step1_v11::#B&B::13_Infectious_Disease::06_Viruses::04_RNA_Viruses, #AK_Step1_v11::#B&B::18_Pulm::03_Other::01_Pneumonia, #AK_Step1_v11::#FirstAid::02_Immunology::04_Immunosuppressants::04_Therapeutic_Antibodies, #AK_Step1_v11::#FirstAid::02_Immunology::04_Immunosuppressants::04_Therapeutic_Antibodies::Palivizumab, #AK_Step1_v11::#FirstAid::03_Microbiology::05_Virology::12_RNA_Viruses, #AK_Step1_v11::#FirstAid::03_Microbiology::05_Virology::20_Paramyxoviruses, #AK_Step1_v11::#FirstAid::03_Microbiology::07_Antimicrobials::32_Antimicrobial_Prophylaxis, #AK_Step1_v11::#OME_banner::Clinical::06_Infectious_Disease::07_Pneumonia, #AK_Step1_v11::#Physeo::06_Micro::05_Viruses::30_Respiratory_Syncytial_Virus_(RSV)_&_Human_Metapneumovirus_(hPMV), #AK_Step1_v11::#SketchyMicro::03_Viruses::02_RNA_(-)_Sense::02_Measles_virus,_mumps_virus,_respiratory_syncytial_virus,_parainfluenza_virus_(Paramyxoviridae), #AK_Step1_v11::^Other::^HighYield::1-HighYield
markdown: false

### Text
<b>Palivizumab</b> is used as <b>{{c2::RSV pneumonia::specific}}
prophylaxis</b> in <u>{{c1::premature infants}}</u>

### Extra
<div>
  <i>prevents <u>pneumonia</u> caused by <b>RSV</b> in <b>premature
  infants</b></i>
</div><img src="paste-4956392259909.jpg">
<div><img src="paste-7009386627132.jpg"></div>

### Lecture Notes


### Missed Questions


### Pathoma


### Boards and Beyond


### First Aid
<img src="tmpmgxeyx51.png"> <img src="tmp9j934i6q.png"> <img src=
"tmp_7qllrso.png"> <img src="tmpkpc172yu.png"> <img src=
"tmp6vsu2omg.png">

### Sketchy
<img src="paste-22479858827267.jpg"> <img src=
"Screen%20Shot%202019-10-17%20at%208.14.25%20AM.png">

### Pixorize


### Physeo


### OME
<div class="ome-widget">
  <a href=
  "https://onlinemeded.org/spa/infectious-disease/pneumonia/acquire?ref=anki">
  <img src="_OME_AnkiFlashcards_Lesson_1.png"></a>
</div>

### Additional Resources


### One by one

